| Prev Close | 64.54 |
| Open | 65.48 |
| Day Low/High | 64.98 / 66.36 |
| 52 Wk Low/High | 53.63 / 71.70 |
| Volume | 7.17M |
Astrazeneca PLC Sponsored ADR (AZN)
66.21
1.67
2.59
NASDAQ
| Exchange | NASDAQ |
| P/E Ratio | 51.70 |
| Div & Yield | N.A. (N.A) |
Let's Put the IQ Healthy Hearts ETF Through Its Paces
A closer look at the fund's composition leads to a few head-scratchers, but most of the names seem to fairly represent its focus.
More Positive Data Points on FibroGen
I haven't mentioned FibroGen in a few weeks - I have been adding on any dip. This is an important finding that Roxa improves left ventricle function of the heart where Epo does not. I suspect the FDA has given FGEN a path forward on Rica. It all c...
We're Changing Our Strategy on AstraZeneca
Even today's earnings beat is not 'moving the needle' enough.
AstraZeneca Is Ready to Rally Again Based on the Chart Pattern
But broadening patterns can be tricky to trade.
Highlighting These 10 Pandemic-Tech Plays in Japan
The Japanese equity market has underperformed this year but looks set to star in 2022. Watch these 10 stocks for strong tech- and Covid-linked gains.
Let's Check Up on 2 Immunology-Focused Oncology ETFs
Here we'll look at the iShares Genomics Immunology and Healthcare ETF and the Cancer Immunotherapy ETF to see how they stack up.
Omicron, Black Friday, Jobs Week, Cybersecurity, Trading Zscaler
I wouldn't expect a lot in the way of economic shutdowns, at least not unless clear evidence presents that people are getting sicker from Omicron.
More Positive Endpoints, Observations and Potential Catalysts at FibroGen
* Back to adcom and FibroGen FGEN, this paper was published in August, 2021 showing that Roxadustat itself does not cause thrombosis, which again, if FDA is fair this time, they will know it wasn't the drug it was the dosage. * One of the main point...
Is Something Up at FibroGen?
* Where is the $100 million of extra cash coming into the company's coffers from between now and year-end? As I discussed in my thesis, FibroGen has done a great job of right sizing the company and preserving cash as it finances its drug research ...
Moderna's Patent Credit, Palantir and ARK, Musk Sells Tesla as EV Stocks Climb
Plus, the intersection of rising inflation and a slowing velocity of money give us reason for pause.
FibroGen Update
* I have begun to add to my holdings based on the company "right sizing" its operations FibroGen is a very speculative and development stage biotech company. Its main product is Roxadustat which treats anemia associated with chronic kidney disease...
How to Play AstraZeneca as Earnings Approach
Let's see how the charts are shaping up ahead of the numbers Friday.
Where the S&P and Nasdaq Stand, The New Green Team, Trading Southwest and Pfizer
With earnings season starting in earnest Wednesday, both indexes have offered investors nothing but lower highs coupled with lower lows since the start of September.
Taiwan Administers First Home-Made Vaccine
Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.
What the Fed Said and Did, Robinhood IPO, Trading Ford, Facebook and ServiceNow
Are traders and investors confused? Possibly. Was that the intent? No, but I think Jerome Powell is fine with that.
The Market's Current Mood Brings Back Memories of Late 2018
Just as fears of Fed tightening and a trade war created buying opportunities in tech and elsewhere in late 2018, arguably overblown fears about the Delta variant's economic impact are creating opportunities now.
Dodging the Snakes, Dissonant Dance With China, Dipping Into the Chip Bowl
Those rattles you hear on the COVID, Fed and political fronts are reasons to tread carefully in the markets.
Tech Rally, Acronym Animal Crackers, Fed, Dimon Hands, Trading Banks and SoFi
The public seems to have resigned itself to dealing with a greater degree of inflation for longer than anything I would have considered to be 'transitory.' The again, the public is often as wrong as the Fed.
If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It
I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.
AstraZeneca Is Moving the Needle
This drugmaker is making a historic upside breakout. Let's check the charts.
Moderna Could Provide a 'Shot in the Arm' for Your Portfolio
Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.
Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?
UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
Agility Rules, Spoiled Whiners, Smell the May Flowers, Ford in My Future
Plus, ServiceNow is a stock worth stalking and Amazon is a stock worth celebrating.
Market Turbulence, Credible FOMC?, GDP, Heavy Earnings Week, COVID in India
So far, for the season, the blended rate of earnings growth for the first quarter now stands at an incredible 33.8%.
I'm Not Bailing on Johnson & Johnson Now
Don't forget, this is a very large company with a lot more than the vaccine going on.
Here's Why I'm Avoiding AstraZeneca Stock
The AZN affair exposes the seedy underbelly of drug manufacturing, and the COVID-19 vaccine is certainly a drug.
Have I Been Given a Dodgy Pfizer Shot in Hong Kong?
Lies, damn lies, and statistics in the vaccine age, as Hong Kong and Macau stop administering the Pfizer/BioNTech drug.
Market Moves, Nasdaq, Be Amphibious, FedCoin, Powell & Yellen, Trading Best Buy
Ever think you would see the day when all cash was digital so the federal government could place a negative interest rate (tax) on savings? I can see this coming from a mile away.
Should You Buy AstraZeneca After Its Positive Vaccine News?
Here's my view on this space and where the money is to be made.
Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD
COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?
